These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 25981649)
1. [Indication of alternate-day treatment with S-1 in patients with oral cancer]. Negishi A; Ogawa M; Kosugi K; Takayama Y; Gomi A; Miyazaki H; Yokoo S Gan To Kagaku Ryoho; 2015 May; 42(5):569-73. PubMed ID: 25981649 [TBL] [Abstract][Full Text] [Related]
2. Alternate-day oral therapy with TS-1 for advanced gastric cancer. Arai W; Hosoya Y; Hyodo M; Yokoyama T; Hirashima Y; Yasuda Y; Nagai H; Shirasaka T Int J Clin Oncol; 2004 Jun; 9(3):143-8. PubMed ID: 15221596 [TBL] [Abstract][Full Text] [Related]
3. Outpatient oral chemotherapy with S-1 for unresectable or distant metastatic head and neck cancer. Maeda M; Yamashita T; Matsunobu T; Araki K; Tomifuji M; Shiotani A Anticancer Res; 2013 Aug; 33(8):3285-9. PubMed ID: 23898093 [TBL] [Abstract][Full Text] [Related]
4. [Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone]. Nakamura M; Koga M; Aoki M; Iwamoto O; Koga C; Kusukawa J Gan To Kagaku Ryoho; 2011 Nov; 38(11):1841-3. PubMed ID: 22083193 [TBL] [Abstract][Full Text] [Related]
5. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)]. Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577 [TBL] [Abstract][Full Text] [Related]
6. [A case of oral squamous cell carcinoma responding to S-1]. Harada K; Tamatani T; Bando T; Yoshida H Gan To Kagaku Ryoho; 2007 Sep; 34(9):1455-8. PubMed ID: 17876145 [TBL] [Abstract][Full Text] [Related]
7. Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinoma. Harada K; Sato M; Ueyama Y; Nagayama M; Hamakawa H; Nagahata S; Yoshimura Y; Osaki T; Ryoke K; Anticancer Drugs; 2008 Jan; 19(1):85-90. PubMed ID: 18043133 [TBL] [Abstract][Full Text] [Related]
8. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy. Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer. Suzuki S; Ishikawa K J Infect Chemother; 2009 Oct; 15(5):335-9. PubMed ID: 19856075 [TBL] [Abstract][Full Text] [Related]
10. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M; Br J Cancer; 2005 Oct; 93(8):884-9. PubMed ID: 16189518 [TBL] [Abstract][Full Text] [Related]
11. [Late phase II study of S-1 in patients with advanced head and neck cancer]. Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B; Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245 [TBL] [Abstract][Full Text] [Related]
12. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer]. Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764 [TBL] [Abstract][Full Text] [Related]
13. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Koizumi W; Narahara H; Hara T; Takagane A; Akiya T; Takagi M; Miyashita K; Nishizaki T; Kobayashi O; Takiyama W; Toh Y; Nagaie T; Takagi S; Yamamura Y; Yanaoka K; Orita H; Takeuchi M Lancet Oncol; 2008 Mar; 9(3):215-21. PubMed ID: 18282805 [TBL] [Abstract][Full Text] [Related]
14. Outpatient chemotherapy with S-1 for recurrent head and neck cancer. Yamashita T; Shinden S; Watabe T; Shiotani A Anticancer Res; 2009 Feb; 29(2):577-81. PubMed ID: 19331206 [TBL] [Abstract][Full Text] [Related]
15. [A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1]. Harada K; Kawashima Y; Uchida D; Yoshida H Gan To Kagaku Ryoho; 2007 May; 34(5):745-7. PubMed ID: 17496449 [TBL] [Abstract][Full Text] [Related]
16. [An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1]. Yamamoto K; Obara S; Mishima K; Nakamura H; Yoshimura Y Gan To Kagaku Ryoho; 2004 Apr; 31(4):635-7. PubMed ID: 15114716 [TBL] [Abstract][Full Text] [Related]
17. A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates. Tsuchiya T; Nagayasu T; Yamasaki N; Matsumoto K; Miyazaki T; Tagawa T; Nakamura A; Minami H; Taniguchi H; Akamine S; Hisano H; Taniguchi Y Clin Lung Cancer; 2012 Nov; 13(6):464-9. PubMed ID: 22424872 [TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of palliative chemotherapy with S-1 for oral cancer patients]. Koga M; Aoki M; Anegawa E; Tezuka M; Iwamoto O; Koga C; Kusukawa J Gan To Kagaku Ryoho; 2007 May; 34(5):719-23. PubMed ID: 17496444 [TBL] [Abstract][Full Text] [Related]
19. [A Case of Alternate-Day Treatment with S-1 in a Patient with Multiple Lung Metastases of Colon Cancer]. Kamata A; Kano T; Hagiwara H; Sarukawa H; Wada Y; Miyamae T; Koizumi M; Takahashi K; Abe Y; Natori J; Uchiyama K Gan To Kagaku Ryoho; 2016 Mar; 43(3):373-5. PubMed ID: 27067859 [TBL] [Abstract][Full Text] [Related]
20. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma. Harada K; Ferdous T; Yoshida H Oncol Rep; 2007 Nov; 18(5):1077-83. PubMed ID: 17914556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]